Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 3 medicines
AIFA · 2 medicines
CBG-MEB · 2 medicines
PHARMAC · 2 medicines
HSA · 2 medicines
Health Canada · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
33 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Aztreonam | United States | 1GM/VIAL, 2GM/VIAL, 500MG/VIAL | injectable | Marketed | Hikma |
| aztreonam | Brazil | Authorised | Instituto Biochimico Indústria Farmacêutica Ltda | ||
| Aztreonam | Brazil | Cancelled | Ariston Inds Quims Ftcas Ltda | ||
| Aztreonam | Brazil | Cancelled | Eurofarma Laboratorios S.A. | ||
| Aztreonam (Fresenius Kabi) | New Zealand | Inj 1 g vial | Funded | ||
| Azactam | United States | 1GM/VIAL, 2GM/VIAL, 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Marketed | Labs Delbert |
| Cayston | United States | 75MG/VIAL | for solution | Marketed | Gilead |
| Azactam in Plastic Container | United States | 10MG/ML, 20MG/ML, 40MG/ML | injectable | Not marketed | Bristol Myers Squibb |
| AZACTAM 1g POLVO PARA SOLUCION INYECTABLE | Spain | 1000 mg | polvo para solución inyectable | Marketed | Galenicum Derma S.L.U. |
| Cayston | European Union | Authorised | Gilead Sciences Ireland UC | ||
| CAYSTON 75 mg POLVO Y DISOLVENTE PARA SOLUCION PARA INHALACION POR NEBULIZADOR | Spain | 75 mg | polvo para solución para inhalación por nebulizador | Marketed | Gilead Sciences Ireland Unlimited Company |
| EmblaveoCombination | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Emblaveo 1,5 G/0,5 G Polvo Para Concentrado Para Solucion Para PerfusionCombination | Spain | 542 mg + 1500 mg | polvo para concentrado para solución para perfusión | Marketed | Pfizer Europe Ma Eeig |
| Azeus | Brazil | Authorised | Newcom Farmaceutica Ltda. | ||
| Azanem | Brazil | Authorised | Instituto Biochimico Indústria Farmacêutica Ltda | ||
| Azactam | New Zealand | Inj 1 g vial | Funded | ||
| Cayston | Italy | Polvere per inalazione | Authorised | Gilead Sciences Ireland Uc | |
| Cayston 75 mg, poeder voor verneveloplossing | Netherlands | Poeder voor verneveloplossing | Authorised | Gilead Sciences Ireland UC | |
| EmblaveoCombination | Italy | Polvere per concentrato per soluzione per infusione | Authorised | Pfizer Europe Ma Eeig | |
| EmblaveoCombination | United States | 0.5GM BASE/VIAL; 1.5GM/VIAL | powder | Marketed | Abbvie |
| Emblaveo 1,5 g/0,5 g poeder voor concentraat voor oplossing voor infusieCombination | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Pfizer Europe MA EEIG | |
| AZACTAM FOR INJECTION 1 g/vial | Singapore | 1 g/vial | injection, powder, for solution | Authorised | Arrotex Pharmaceuticals Singapore Pte. LTD. |
| Cayston | Canada | 75 MG / VIAL | Powder For Solution | Marketed | Gilead Sciences Canada INC |
| Emblaveo Powder for Concentrate for Solution for Infusion 1.5G/0.5GCombination | Singapore | 0.5 g/vial + 1.5 g/vial | injection, powder, for solution | Authorised | Pfizer Private Limited |
| EmblaveoCombination | Croatia | Marketed |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
